[GERD/reflux esophagitis].
Hongo
Michio
M
Department of Comprehensive Medicine, Tohoku University Hospital.
Tamura
Daisaku
D
D000863:Antacids / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D004942:Esophagitis, Peptic / Q000145:classification / Q000209:etiology / Q000628:therapy; D004945:Esophagoscopy; D005744:Gastric Acid / Q000378:metabolism; D005769:Gastrointestinal Motility; D016481:Helicobacter Infections / Q000150:complications; D016480:Helicobacter pylori; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D011379:Prognosis; D054328:Proton Pump Inhibitors; D012720:Severity of Illness Index
D000863:Antacids; D004791:Enzyme Inhibitors; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors